Therefore, these data suggest that, although macrolide Az mediated NLRP3 suppression could interfere with maintenance of the inflammatory milieu required for the survival of cancer cells, its potential to increase angiogenesis and metastasis should be considered with long-term use in cancer patients. The gene discussed is NLRP3; the disease is cancer.